Revolution Medicines, Inc. · NASDAQ:RVMD
Kim Lorence H. sold 17,090 Revolution Medicines, Inc. shares (Form 4)
Traded Sep 8, 2026 · Filed Sep 10, 2026
On Sep 8, 2026, Kim Lorence H. (Director) sold 17,090 Revolution Medicines, Inc. shares at an average US$209.82 for US$3.59M under a trading plan, leaving 0 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 17,090 shares
- Price
- US$209.82 average (US$206.60 to US$212.27)
- Value
- US$3.59M
- Holding after
- 0 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | Sale | 706 | US$206.60 | 16,384 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 999 | US$207.33 | 15,385 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 3,587 | US$208.55 | 11,798 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 2,853 | US$209.56 | 8,945 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 4,730 | US$210.50 | 4,215 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 3,844 | US$211.36 | 371 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 371 | US$212.27 | 0 | Indirect |
Source
Related
- Revolution Medicines, Inc.
- Kim Lorence H.
- Revolution Medicines, Inc. shareholders
- Form 4 · Kim Lorence H. · Sep 2, 2026
- Form 4 · Kim Lorence H. · Jun 23, 2026
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026